- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00864539
Comparison of the Efficacy of Calcium-cholecalciferol Foodstuffs and Calcium-cholecalciferol Supplement
November 12, 2011 updated by: Tirang R. Neyestani, National Nutrition and Food Technology Institute
The Prevalence of Vitamin D Insufficiency in Primary School Children and Comparison of the Effect of Calcium-Vitamin D-Fortified Milk, -Orange Juice and Calcium-Vitamin D Supplement
This study is conducted in two phases.
At the first phase, the prevalence of vitamin D insufficiency in primary school-children in Tehran is determined during the cold seasons of 2008.
Then, the efficacy of calcium-vitamin D-fortified milk, -orange juice and supplement is compared in six selected primary schools.
Study Overview
Status
Completed
Conditions
Detailed Description
At the first step, serum 25-(OH)D, PTH(parathyroid hormone), osteocalcin, bone alkaline phosphatase, calcium, phosphorous, and magnesium is evaluated.
Anthropometric and dietary intake data is also collected.
In the second phase, we have 6 experimental groups: (1) plain milk; (2) calcium-vitamin D-fortified milk (containing 500 mg Ca and 100 IU vitamin D/200 mL package); (3) plain orange juice; (4) fortified orange juice containing equal amounts of calcium and vitamin D as fortified milk; (5) calcium-vitamin D supplement (500 mg calcium and 200 IU vitamin D); and (6) placebo.
Each group consists of 40-60 children (9-11 years) from both sexes.
All above-mentioned biochemical, anthropometric and dietary intake data is collected both in the beginning and in the end of interventional period.
Study Type
Interventional
Enrollment (Actual)
585
Phase
- Phase 2
- Phase 3
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
9 years to 11 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age: 9-11 years
- Being healthy (no apparent clinical disease)
- Informed consent signed by child's parent(s)
Exclusion Criteria:
- Subjects receiving vitamin D, calcium or omega-3 supplement
- Unwillingness to continue the study
- Subjects with type 1 diabetes, allergy, kidney disorders
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: fortified milk
daily intake of milk fortified with 100 IU vitamin D and 500 mg calcium/200 mL
|
daily intake of milk fortified with 100 IU vitamin D and 500 mg calcium/200 ml package for 10 weeks
Other Names:
|
Active Comparator: plain milk
daily intake of 200 mL plain milk
|
daily intake of 200 ml plain milk
Other Names:
|
Experimental: fortified orange juice
daily intake of orange juice fortified with 100 IU vitamin D and 500 mg calcium
|
daily intake of orange juice fortified with 100 IU vitamin D and 500 mg calcium/250 ml package
Other Names:
|
Active Comparator: plane juice
subjects receiving plain orange juice
|
daily intake of 250 ml plain orange juice
Other Names:
|
Experimental: vitamin D-Ca supplement
Subjects receiving daily supplement containing 500 mg + 200 IU vitamin D
|
daily calcium-vitamin D supplement (500 mg calcium + 200 IU vitamin D)
Other Names:
|
Placebo Comparator: Placebo
Subjects receiving daily placebo containing 1g starch
|
daily placebo
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Serum Levels of 25hydroxy Vitamin D(25(OH)D)Compared to the Due Control Group
Time Frame: 10 weeks
|
Serum level of 25(OH)D was determined using competitive protein binding assay (CPBA) method.
|
10 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Tirang R. Neyestani, Ph.D., National Nutrition and Food Technology Research Institute, P.O. Box 19295-4741
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2007
Primary Completion (Actual)
February 1, 2009
Study Completion (Actual)
June 1, 2010
Study Registration Dates
First Submitted
March 17, 2009
First Submitted That Met QC Criteria
March 17, 2009
First Posted (Estimate)
March 18, 2009
Study Record Updates
Last Update Posted (Estimate)
November 21, 2011
Last Update Submitted That Met QC Criteria
November 12, 2011
Last Verified
November 1, 2011
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P/25/47/2027
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on fortified milk
-
Gadjah Mada UniversityUnknown
-
Hospices Civils de LyonCompletedCardiometabolic RiskFrance
-
Société des Produits Nestlé (SPN)CompletedNutritional Status | Child Nutrition Sciences | ToddlersPhilippines
-
NestléCompletedGrowth | Learning | ToddlersPhilippines
-
Instituto Nacional de Salud Publica, MexicoMead Johnson NutritionCompletedUndernutritionMexico
-
FrieslandCampina WAMCO Nigeria PLCLagos State UniversityUnknownEnterobacteriaceae Infections | Nutritional Deficiency | Iron-deficiency Anemia | Nutritional Stunting | Nutritional Wasting | Malnutrition; Mild
-
National Center for Research Resources (NCRR)Baylor College of MedicineCompletedSepsis | Necrotizing EnterocolitisUnited States
-
Indonesia UniversityLudwig-Maximilians - University of MunichCompletedGestational Age and Weight Conditions | Breast Feeding, Exclusive | Low; BirthweightIndonesia
-
NestléFood and Nutrition Research Institute, Philippines; ETH Zurich (Switzerland)Completed
-
Tehran University of Medical SciencesUNICEFCompletedVitamin D DeficiencyIran, Islamic Republic of